Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)

Summary

In this study the investigators will recruit hypertensive subjects with higher than average uric acid levels to test the effect of lowering uric acid with febuxostat on several measures as listed below. This will be a randomized, double-blind, placebo-controlled, parallel group study.

Timeline

Start

2011-03

Primary completion

2013-09

Completion

2014-01

Drugs

Indications